09.09.14
Orthopedic implant firm Implanet has published a white paper titled “Adolescent Idiopathic Scoliosis Treated by Posteromedial Translation Using Jazz Sublaminar Bands.”
Based near Bordeaux, France, Implanet specializes in vertebral and knee-surgery implants. Jazz, the company's flagship product, is a posterior implant designed to treat spinal pathologies requiring vertebral fusion surgery.
“These interim results of a major multi-centre study carried out with the Jazz system confirm two pivotal parameters: clinical efficiency and patient safety,” said Alain Meunier, Implanet’s clinical and scientific affairs director. “For Implanet, these results validate, from a clinical perspective, the concept of sublaminar bands in the treatment of adolescent scoliosis.”
The study, carried out by the department of pediatric orthopedic surgery at the Robert Debré hospital, which is part of Paris Diderot University, includes details of the results obtained with the help of the Jazz implant in the surgical treatment of adolescent idiopathic scoliosis by posteromedial translation, in particular in terms of the restoration of frontal and sagittal alignment. The study was conducted with 12-month follow-up of a consecutive series of 20 patients.
“This post-market study supplements the clinical data that has enabled the Jazz implant to receive the CE mark in 2011 and FDA clearance in 2012,” said CEO Ludovic Lastennet. “For our team and partners, these results represent the validation of our development and innovation strategy. We are continuing our research to permanently improve the surgical procedure and the care provided to patients suffering from serious spinal deformity, with particular focus on adolescent conditions.”
Based near Bordeaux, France, Implanet specializes in vertebral and knee-surgery implants. Jazz, the company's flagship product, is a posterior implant designed to treat spinal pathologies requiring vertebral fusion surgery.
“These interim results of a major multi-centre study carried out with the Jazz system confirm two pivotal parameters: clinical efficiency and patient safety,” said Alain Meunier, Implanet’s clinical and scientific affairs director. “For Implanet, these results validate, from a clinical perspective, the concept of sublaminar bands in the treatment of adolescent scoliosis.”
The study, carried out by the department of pediatric orthopedic surgery at the Robert Debré hospital, which is part of Paris Diderot University, includes details of the results obtained with the help of the Jazz implant in the surgical treatment of adolescent idiopathic scoliosis by posteromedial translation, in particular in terms of the restoration of frontal and sagittal alignment. The study was conducted with 12-month follow-up of a consecutive series of 20 patients.
“This post-market study supplements the clinical data that has enabled the Jazz implant to receive the CE mark in 2011 and FDA clearance in 2012,” said CEO Ludovic Lastennet. “For our team and partners, these results represent the validation of our development and innovation strategy. We are continuing our research to permanently improve the surgical procedure and the care provided to patients suffering from serious spinal deformity, with particular focus on adolescent conditions.”